InfoBionic rebrands to ‘InfoBionic.Ai’, emphasizing AI-driven ECG focus.

Today, InfoBionic.Ai, a digital health firm offering AI-driven diagnostic remote patient monitoring solutions, announced a name change from ‘InfoBionic’ to ‘InfoBionic.Ai.’ This shift underscores the company’s ongoing dedication to harnessing artificial intelligence in virtual cardiac care. InfoBionic has long been…

Read MoreInfoBionic rebrands to ‘InfoBionic.Ai’, emphasizing AI-driven ECG focus.

S2 Genomics Unveils Innovative Single Cell FFPE Sample Prep Solution

S2 Genomics, a leading innovator in tissue sample preparation systems, has unveiled its latest groundbreaking product, the Singulator™ 200+ System. This state-of-the-art technology represents a significant advancement in automated sample preparation specifically designed for single-cell formalin-fixed, paraffin-embedded (FFPE) tissues. By…

Read MoreS2 Genomics Unveils Innovative Single Cell FFPE Sample Prep Solution

SimBioSys Introduces TumorSight Plan: Clinical Support for Early-Stage Breast Cancer

SimBioSys®, an innovative TechBio firm harnessing spatial biophysics with artificial intelligence (AI) and computational modeling to revolutionize precision medicine in cancer, is thrilled to unveil its latest clinical offering, TumorSight Plan. This groundbreaking application is the first of its kind,…

Read MoreSimBioSys Introduces TumorSight Plan: Clinical Support for Early-Stage Breast Cancer